|
Post-graduate researcher / PhD student
Federal University of Minas Gerais (FUMG),Brazil
Email: camilasimoesf@gmail.com
VALIDATE Role: Network Affiliate
Research Keywords
Leishmaniasis, treatment, vaccines, diagnostics, animal models
Biography
Graduated in Biological Sciences (2019). Master's degree in the Health Sciences Program: Infectology and Tropical Medicine (2021).
In addition, currently PhD student in the Health Sciences Program: Infectology and Tropical Medicine and academic visitor in the University of Southampton. Interested in research in the field of Molecular Biology; Immunology, Biotechnology and Parasitology, focusing on Diagnosis, Treatment and Vaccines for Leishmaniasis.
Related websites
Key Publications
- Freitas, C.S., Oliveira-da-Silva, J.A., Lage, D.P. et al. Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis. Parasitol Res 120, 321–335 (2021) - https://doi.org/10.1007/s00436-020-06971-2
- Freitas CS, Lage DP, Oliveira-da-Silva JA, Costa RR, et. al. In vitro and in vivo antileishmanial activity of b-acetyl-digitoxin, a cardenolide of Digitalis lanata potentially useful to treat visceral leishmaniasis. Parasite 28, 38 (2021). DOI: 10.1051/parasite/2021036
- Freitas, C. S., Lage, D. P., Machado, A. S., et al. Exploring drug repositioning for leishmaniasis treatment: Ivermectin plus polymeric micelles induce immunological response and protection against tegumentary leishmaniasis. Cytokine, volume 164 (2023).
- https://doi.org/10.1016/j.cyto.2023.156143
- Freitas, C. S., Santiago, S. S., Lage, D. P., et al. In vitro evaluation of antileishmanial activity, mode of action and cellular response induced by vanillin synthetic derivatives against Leishmania species able to cause cutaneous and visceral leishmaniasis. Experimental Parasitology, volume 251 (2023). https://doi.org/10.1016/j.exppara.2023.108555
-
|
